Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Chazz Smith told a rally of over 80 people in the Capitol rotunda that his younger cousin had everything, yet opioids still took his life in 2016 . Authorities blamed counterfeit pills laced with fentanyl that looked like generic Vicodin. Smith said Prince's death shows the power that addiction can hold on anyone. "We've lost legends, we've lost potential legends, and that's a shame," Smith said. The rally preceded a hearing before a House health and human services committee on a bill to require manufacturers and wholesalers that sell or distribute opioids in Minnesota to pay registration fees ranging as high as $500,000 for the biggest companies. The current fee is just $235. The measure is a different approach from the "penny a pill" tax that passed the Senate last year but stalled out in the House amid industry opposition. It would raise about $20 million annually to fund prevention, treatment and education programs, and to support county child protection agencies that have been swamped by the crisis. Lt. Gov. Peggy Flanagan told the gathering that passing the bill is a priority for Democratic Gov. Tim Walz. Bill sponsors said at a news conference that the industry should pay its fair share for a crisis that it helped create. They pointed out that more than 400 people died of opioid overdoses in Minnesota in 2017, according to the Minnesota Department of Health. "In communities across the state, it appears that this opioid crisis that we're in really has no end in sight," said Rep. Liz Olson, a Duluth Democrat. "Without this swift legislative action, there indeed might not be an end. Parents have lost children, teachers have lost students, our first responders are asked to respond to impossible situations, and no other family deserves to go through this." Other leading sponsors include Rep. Dave Baker, a Republican from Willmar, and Sen. Chris Eaton, a Brooklyn Park Democrat, who have both lost children to opioid overdoses. Baker's son, Dan, 25, died in 2011 of a heroin overdose after becoming addicted to opiate pain pills for a back injury. Eaton's daughter, Ariel, was 23 when she died of a heroin overdose in 2007. "I don't want other families to go through the trauma that I did," Eaton said. Sen. Julie Rosen, a Republican from Vernon Center, said the manufacturers and distributors have been "kicking and screaming a little bit" but now tell her they want to be part of the solution. "I asked them, 'What does that look like?' and I have not received an answer," she added. "We're spending billions on an issue you helped create," Rosen said. "I don't think we're asking for a whole lot for the amount that they are shipping and manufacturing for the state of Minnesota, and the amount of deaths that we have." The Pharmaceutical Research and Manufacturers of America, also known as PhRMA, opposed last year's bill. While the trade group says it supports "an extensive set of policy recommendations ," including measures to curb overprescribing, it opposes this year's bill as well. "Unfortunately, what's being proposed taxing legitimately prescribed medicines that patients rely on for legitimate medical needs to raise revenues for the state ignores evidence-based solutions, sets a dangerous precedent and ultimately won't help patients and families," Nick McGee, the trade group's director of public affairs, said in an email to The Associated Press. Claim: Minnesota lawmakers: Tax drug makers over opioid crisis.

Output: Lawmakers and activists are making a push to force drug companies to pay more of the costs of the opioid crisis, and they got a boost Wednesday from a cousin of the most famous Minnesotan to die from the addictive drugs, the late rock star Prince.

Input: Consider Input: Paragraph: "The story does not discuss the costs of annual mammography screening, or even provide a range of costs. The story does not discuss any health care policy cost repercussions of breast cancer screening recommendations. The story does not discuss the cost of unnecessary biopsies or other treatments for women who have a false positive diagnosis via mammography (greater in women 40-49). The story highlights the 26 percent difference in breast cancer death rates, but fails to include any information about the overall risk. The researchers reported that based on their results you would have to screen 1252 women for a decade in order to prevent one breast cancer death. In other words, for the remaining 1251 women, a decade of mammograms did not alter their breast cancer mortality. Although this story does not go into detail about the potential harms of screening mammography, it does include comments from independent experts who point out that the scans do lead to the diagnosis and treatment of women whose tumors would never have become life-threatening. This story briefly explains key features of this study. It also includes critiques from independent experts who note limitations of the study design and analysis although the statement that the researchers ""did not compare the broader breast cancer death rates""in the counties"" is unclear. Overall, there is much more the Times could have done to analyze methodological questions surrounding the Swedish study. (For example, read our blog on this matter.) Interviews with Peter Gotzsche and with Donald Berry saved the story. But so much more could have been done another reason why more than 471 words should have been devoted to the reporting. The story does not discuss the prevalence of breast cancer among women in their 40s. That omission would not usually be considered disease mongering, but since surveys indicate most people overestimate the risk of breast cancer among women in their 40s, failing to mention the actual rates leaves those misconceptions intact. The story does include comments from experts who raise concerns about overdiagnosis; that is, the number of breast tumors discovered that are not actually life-threatening. A strong point of this story is the inclusion of comments from several independent experts with a variety of perspectives on the meaning of the latest study results. The story does not mention any potential conflicts of interest, but the researchers did not list any in their journal article. Although not discussed in detail, the story does mention that the United States Preventive Services Task Force has questioned the value of screening mammograms for women younger than 50, thus implying that not being screened is an option to consider. The availability of mammography was not explicitly addressed, but we can't criticize the story for that. Instead, we give a Not Applicable score for this criterion. This story could have done a better job explaining how this study and its methods are different from earlier research on the topic.But two things lead us to give it a barely satisfactory score. First, there was a brief attempt to mention the unique ""circumstances"" of the Swedish study. Second, the story also pointed out that there's a historical ideological pattern in the study authors' work noting that they ""have long been advocates of mammography screening."" It's clear that the story was not based on a news release." Claim: Mammogram Benefit Seen for Women in Their 40s

Output: This story includes strong comments from independent experts that can help readers get a broader understanding of the results of a study that compared breast cancer death rates among women in their 40s who lived in areas of Sweden that did or did not offer routine mammography. However, because the story reports only the percentage difference in death rates, without including absolute numbers or the number of women who need to be screened to prevent one death, readers may get the impression that the effect of mammography was larger than what the researchers actually reported. People commonly overestimate the risk of breast cancer death among women in their 40s. By not including any information about the absolute numbers of deaths among women in this study or in the population at large, the story misses an opportunity to correct common misconceptions.

Input: Consider Input: Paragraph: The coffin, one of three brought the same morning, came hours after officials said 13 elderly residents had diedin the home since March 11 and that more than 80 others were believedto have the coronavirus. Most of the dead were aged over 90, an official at the regional healthauthority told Reuters. Authorities have not been able to establish the cause of death in most cases. "The deliveries are non-stop. There are going to be more on Monday," the delivery man said as he removed the casket's plastic cover. The facility in Paris' 12th district is one of several care homes across France to be hit by thecoronavirus outbreak. There have been large numbers of deaths too at retirement homes in Italy and Spain. Almost 1 million people reside in care homes in France. In the Paris region alone, the regional health authority saysthat 148 out of the 700 homes in its network have reported coronavirus cases and at least 61 residents have died. The Rothschild Foundation home in Paris was put on red alerton March 6 as the epidemic took hold. Staff were givenstricter entry protocols, told to wear gloves and masks atall times, disinfect everything and urged to isolate suspectedcases. "We knew it was coming. The first two people with symptoms weretested and then isolated, but once it was established that theyhad it, we stopped testing because it's then a cluster. Youcan't allow it to spread," said a health worker aware of the situation. Since then all residents have been confinedto their rooms where they are fed and washed. But whilethe number of new cases has slowed, the deaths continue. Executives at the home did not respond to Reuters phone calls seeking detailed information about what was happening in the home, but in a brief exchange, one executive described the situation at the facility as very tough. France's official coronavirus death toll stands at some 1,100 people, but that does not include deaths outside hospitals. Fatalities in nursing homes have surged recently with dozens of deaths reported across the country. "When you don't have enough staff andequipment and need to care for fragile people then itleads to a high mortality rate. When it enters into a nursinghome, you are going to see 20% of residents die," saidThierry Amouroux, a nurse and representative at the NationalUnion for Professional Nurses. Seniorcare home representatives warned the Health Minister in a letter seen by Reutersthat workers in the homes needed 500,000 masks. At least 100,000 people could die if the situation was not brought under control, they wrote. Jerome Larche, an intensive care doctor in Montpellier, whosecompany also operates care homes, said it was critical to avoid mass contaminations. "Mostof the residents can't be taken to intensive careso if there are contaminations, there will be deaths," Larche said. At the Bergeron-Grenier care home in western France, half of carershave opted to confine themselves within the home to reduce the risk of spreading the coronavirus. "Before, we were always afraid. No matter how careful wewere, we still had this fear of infecting our residents bybringing the virus from outside," administrative assistantPatricia Vandebrouck said. Claim: 'Delivering coffins non-stop': coronavirus stalks a Paris nursing home.
Output: Outside a Paris retirement homeon Wednesday, a director rushed out and told the man delivering a coffin to use a side entrance, away from prying eyes.